Loading…
This event has ended. Create your own event on Sched.
Welcome to the Science Summit at UNGA76, a major contribution to advancing Science for the UN SDGs. Online from 14- September - 5 October 2021.
ISC will organise the second edition of the UNGA76 Science Summit around the 76th United Nations General Assembly (SSUNGA76) in September 2021. The objective of the virtual meeting will be to raise awareness of the role and contribution of science to the attainment of the United Nations Sustainable Development Goals. It will demonstrate initiatives that provide models for global science mechanisms and activities in support of the SDGs, particularly in science infrastructure and capacity building. Science is and will enable sustainable economic, environmental, and societal development. Science is more than a funding prioritisation exercise: science is impacting all areas of policy-making and is playing a more critical role in how policy objectives are achieved and the consequent benefit to people everywhere, including responses to global challenges.
Engagement with policy leadership is more important than ever: UNGA76 is a unique forum for science to demonstrate how policy and political leadership can benefit from innovation. Central to this is the role of nonstate actors and the multilateral fora, which increasingly determine how priorities are set. Science needs to be part of this dialogue and inform outputs through thought leadership, evidence, insights, analysis, and innovation.

Registration is available here.
avatar for Mark Bale

Mark Bale

Genomics England, DHSC
Senior Civil Servant
Mark Bale is a Senior Civil Servant with responsibilities for genomic science policy particularly genomic medicine and pathogen genomics.
He was the Programme Director for the 100,000 Genomes Project.  Since 2015 he has been partly seconded to Genomics England Ltd as Head of Science Partnerships supporting strategy, collaborations and public engagement.   
His responsibilities are for policy on emerging healthcare science areas and their ethical, legal and policy implications. This includes regenerative medicine, gene therapy, genome editing, rare diseases and bioethics. He also had professional and management responsibility for scientists in the wider Department. 
He represents the UK on bioethics, genomics, and biotechnology at international committees, including work on the EU 1+M Genomes Initiative.  He was Chair of the Committee on Bioethics at the Council of Europe from 2014-2016. 
Mark has a research background in microbial genetics and joined the Department of Health in 1999 after post-doctoral research on the safety of GMOs and pathogens.